Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-10-31
2010-12-21
Landsman, Robert (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300, C530S388100, C530S388150, C530S388220, C530S389100, C530S391300
Reexamination Certificate
active
07855278
ABSTRACT:
The present invention is directed to novel polypeptides having sequence similarity to Stra6, a murine retinoic acid responsive protein, and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4485045 (1984-11-01), Regen
patent: 4496689 (1985-01-01), Mitra
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4657760 (1987-04-01), Kung et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4943529 (1990-07-01), Van Den Berg et al.
patent: 4975278 (1990-12-01), Santer et al.
patent: 4997852 (1991-03-01), Minton et al.
patent: 5010182 (1991-04-01), Brake et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5122469 (1992-06-01), Mather et al.
patent: 5206344 (1993-04-01), Katre et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5654010 (1997-08-01), Johnson et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 6187819 (2001-02-01), Fisher et al.
patent: 6525174 (2003-02-01), Young et al.
patent: 2003/0021788 (2003-01-01), Pennica et al.
patent: 2003/0149239 (2003-08-01), Baker et al.
patent: 2003/0187201 (2003-10-01), Baker et al.
patent: 2003/0187202 (2003-10-01), Baker et al.
patent: 2003/0187203 (2003-10-01), Baker et al.
patent: 36776 (1981-09-01), None
patent: 073657 (1983-03-01), None
patent: 117058 (1984-08-01), None
patent: 117060 (1984-08-01), None
patent: 139383 (1985-05-01), None
patent: 307247 (1988-03-01), None
patent: 362179 (1990-04-01), None
patent: 03089 (1990-05-01), None
patent: 394538 (1990-10-01), None
patent: 404097 (1990-12-01), None
patent: 616812 (1994-09-01), None
patent: WO 81/01145 (1981-04-01), None
patent: WO 84/03564 (1984-09-01), None
patent: WO 87/05330 (1987-09-01), None
patent: WO 88/07378 (1988-10-01), None
patent: WO 89/05859 (1989-06-01), None
patent: WO 90/10048 (1990-09-01), None
patent: WO 90/13641 (1990-11-01), None
patent: WO 90/13646 (1990-11-01), None
patent: WO 91/00357 (1991-01-01), None
patent: WO 91/00360 (1991-01-01), None
patent: WO 91/04753 (1991-04-01), None
patent: WO 93/11161 (1993-06-01), None
patent: WO 93/17041 (1993-09-01), None
patent: WO 93/18186 (1993-09-01), None
patent: WO 94/11026 (1994-05-01), None
patent: WO 95/32221 (1995-11-01), None
patent: WO 96/07399 (1996-03-01), None
patent: WO 96/27011 (1996-09-01), None
patent: WO 96/40072 (1996-12-01), None
patent: WO 97/03692 (1997-02-01), None
patent: WO 97/33551 (1997-09-01), None
patent: WO 98/54963 (1998-12-01), None
patent: WO 99/47162 (1999-09-01), None
patent: WO 01/12660 (2001-02-01), None
Alberts et al., “Gene Expression Can Be Controlled by a Change in mRNA Stability”,Molecular Biology of the Cell, Chap. 9, pp. 464-466 (1994).
Alitalo et al., “Oncogene Amplification in Tumor Cells”,Adv. Cancer Res., 47:235-281 (1986).
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”,Nucleic Acids Res. 25(17):3389-3402 (1997).
American Cancer Society,Cancer Facts and Figures, Atlanta, Georgia: American Cancer Society, Inc., pp. 1-44 (2002).
Anderson et al., “Direct Interactions of Coxsakievirus B3 with Immune Cells in the Splenic Compartment of Mice Susceptible or Resistant to Myocarditis”,Science256, 808-813 (1992).
Aquino et al., “Effect of the Combined Treatment with 5-Fluorouracil, γ-Interferon or Folinic Acid on Carcionoembryonic Antigen Expression in Colon Cancer Cells”,Clinical Cancer Research, 4(10): 2473-2481 (Oct. 1998).
Athauda et al., “Entrapment and Inhibition of Human Immunodeficiency Virus Proteinase by a 2-Macroglobulin and Structural Changes in the Inhibitor”,J. Biochem., 113:742-746 (1993).
Ausubel et al.,Current Protocols of Molecular Biology, John Wiley and Sons (1997).
Barker et al., “The Yin-Yang of TCF/β-Catenin Signaling”,Adv. Cancer Res., 77:1-24 (2000).
Baselga et al., “Phase II Study of Weekly Intravenous Recombinant Humanized Anti-pi 85her2 Monoclonal Antibody in Patients With HER2
eu-Overxpressing Metastatic Breast Cancer”,J. Clin. Oncol., 14:737-744 (1996).
Baselga et al., “HER2 Overexpression and Paclitaxel Sensitivity in Breast Cancer: Therapeutic implications”,Oncology, 11(3 Suppl 1):43-48 (1997).
Beach et al., “High-frequency transformation of the fission yeastSchizosaccharomyces pombe”, Nature, 290:140 (1981).
Beal et al., “Second Structural Motif for Recognition of DNA by Oligonucleotide-Directed Triple-Helix Formation”,Science, 251:1360(1991).
Beckmann et al., “Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors”,EMBO J., 13:3657 (1994).
Behrens et al., “Functional Interaction of β-catenin with the transcription factor LEF-1”,Nature, 382:638-642 (1996).
Bergstein et al., “Isolation of Teo Novel WNT Genes, WNT14 and wnt15, One of Which (WNT15) Is Closely linked to WNT3 on Human Chromosome 17q21”,Genomics, 46:450-458 (1997).
Bidyut Roy et al., “Synergistic Activation of Retinoic Acid (RA)-Responsive Genes and Induction of Embryonal Carcinoma Cell Differentiation by a RA Receptor α (RARα)-, RARβ- or RARγ-Selective Ligand in Combination with a Retinoid X Receptor-Specific Ligand”,Mol. Cell. Biol., 15(12):6481-7 (1995).
Bishop, Michael J., “Molecular Themes in Oncogenesis”,Cell, 64:235-248 (1991).
Blast Alignments of SEQ ID No. 1 and SEQ ID No. 4 with sequences of AI 684707; AI 760170 and SEQ ID No. 36 of WO 98/54963 dated Jan. 29, 2004.
Boerner et al., “Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes”,J. Immunol., 147(1):86-95 (1991).
Bolivar et al., “Construction and characterization of new cloning vehicles”,Gene, 2:95-113 (1977).
Boring et al., “Cancer Statistics, 1993”,CA Cancel J. Clin., 43:7 (1993).
Bouillet et al., “Efficient Cloning of cDNA of Retinoic Acid-Responsive Genes in P19 Embryonal Carcinoma Cells and Characterization of a Novel Mouse Gene, Stra1 (Mouse LERK-2/Eplg2)”,Dev. Biol., 170:420-433 (1995).
Bouillet et al., “Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein”,Mechanisms of Development, 63:173-186 (1997).
Boven and Winograd, eds.,The Nude Mouse in Oncology Research, CRC Press, Inc., 1991.
Bowie, J. et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”,Science, 247:1306-1310 (1990).
Bradley, Allan , “Production and analysis of Chimaeric mice” in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E. J. Robertson, ed. (IRL. Oxford, 1987), 5:113-152.
Braxton and Wells, “Incorporation of Stabilizing Ca2+-Binding Loop into Subtilisin BPN”,Biochemistry, 31:7796-7801 (1992).
Brennan et al., “Preparation of Bispecific Antibodie
Pennica Diane
Smith Victoria
Wood William I.
Genentech Inc.
Landsman Robert
Merchant & Gould P.C.
LandOfFree
Antibodies to Stra6 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to Stra6 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to Stra6 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201609